• The site will expand capabilities to enable development in the fast-growing cardiovascular and advanced therapy markets.

Telford, PA – Solesis, a leader in the custom design, development, and manufacturing of textile- and polymer-based healthcare solutions for the medical device and biopharmaceutical industries, has announced plans to build a new manufacturing site in Costa Rica. This is the first site dedicated to producing implantable textile components, polymer-based devices and components, and single-use technologies. The Solesis family of companies is comprised of Secant Group, Polyzen, Charter Medical and SanaVita Medical, who together enable technologies and therapies for next-generation patient care.

“Expanding into Costa Rica will significantly increase our global capacity, enabling us to rapidly expand and optimize our resources to provide our customers with comprehensive business continuity avenues that mitigate supply chain risks,” said Jeff Robertson, Chief Operating Officer of Solesis. “Costa Rica is a global medical device hub and a prime location for expanding the production of our critical healthcare solutions. In fact, many of our customers already have established manufacturing operations in this region and we look forward to continued collaboration with them.”

The world-class facility is scheduled to begin operations in the spring of 2025 in the Greenpark Free Trade Zone, the first industrial park and Free Trade Zone in Latin America that is environmentally sustainable. The new site will encompass cleanrooms to produce high-quality healthcare solutions that are critical to customers, and ultimately to the patients they serve.

“This expansion is a significant milestone for Solesis and we are looking forward to being part of the San Jose community,” said Lindsay Walker, Vice President of Human Resources of Solesis. “We are excited to work with the strong talent pool that Costa Rica offers and plan to announce which roles we will be recruiting for in the latter half of 2024. When fully staffed, the site will employ approximately 100 employees.”

“We extend a warm welcome to Solesis as a significant contributor to the rapidly expanding medical devices industry in our country. Our leadership, talent pool, extensive experience, and sterling reputation in the precision and medical equipment sector (constituting 42% of the country’s exports in 2023) have inspired confidence, leading companies such as Solesis to choose Costa Rica as the location for establishing their facility,” said Manuel Tovar, Minister of Foreign Trade.

“The skilled workforce of Costa Rica, coupled with its strategic location and the proficiency we’ve developed in the medical devices sector, has led a multinational corporation to choose our country for expanding its operations. This decision not only enhances our international reputation but also generates new employment opportunities, fosters connections with local businesses, and contributes to the overall development of the Costa Rican economy”, said Laura López, CEO of Trade and Investment Promotion Agency  of Costa Rica (PROCOMER).

About SolesisSolesis is a leader specializing in biomaterials for the life sciences industry. Operating through its subsidiaries Secant Group, Polyzen, SanaVita and Charter Medical,  , Solesis develops and manufactures critical components and technologies for the medical device and biopharmaceutical industries. Headquartered in Telford, Pennsylvania, Solesis employs more than 450 people across five production facilities located in Pennsylvania and North Carolina. For more information, visit www.solesis.com.